Combined with our study, by highlighting the presence of PIK3CA mutations in macrophages and epithelial cells and their potential role in tumor progression and drug response, this research suggests avenues for the development of targeted therapies as well as the possibility of using PIK3CA mutation status to guide treatment decisions, which may be possible leads to more effective treatment of CC. The gene discussed is PIK3CA; the disease is neoplasm.